Načítá se...
ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis
Therapeutic targeting of ASCT2, a glutamine transporter that plays a major role in glutamine uptake in cancer cells, is challenging because ASCT2 also has a biological role in normal tissue. In this study, we report our novel finding that ASCT2 is physically associated in a molecular complex with ep...
Uloženo v:
| Vydáno v: | Cancer Lett |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5017913/ https://ncbi.nlm.nih.gov/pubmed/27450723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2016.07.020 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|